Internal Medicine - Issue 12/2013
Original Contributions
1043
1049
Efficacy and safety of vildagliptin as a second-line therapy vs other oral antidiabetic agents in patients with type 2 diabetes: Czech results within the worldwide prospective cohort EDGE study
M. Haluzík, V. Veselá, J. Gerle, M. Brada, L. Dohnalová, T. Edelsberger, J. Houdová
Review
1057
Indicators of inflammation in patients with coronary atherosclerosis – role of usCRP in diagnosis and disease progression prediction
M. Samoš, R. Pullmann, S. Funiak, M. Stančík, M. Mokáň
1065
Contemporary view on liver impairment in heart failure
K. Vyskočilová, L. Špinarová
1073
Guidelines
1081
Present and future of pharmaco-arteriothromboprophylaxis in clinical practice. Guidelines of Angiology Section of Slovak Medical Chamber
P. Gavorník– , A. Dukát, Ľ. Gašpar
Case Report
1107
1111
Serious risk related to oral use of sodium phosphate solution
I. Hoffmanová, M. Anděl
1117
Histiocytic sarcoma
E. Létalová, M. Moulis, M. Klincová, R. Koukalová, Z. Řehák, F. Folber, Z. Adam, J. Mayer
Actuality
1124
Effects of the angiotensin receptor blocker Valsartan (Valsacor®) on arterial pressure, indices of myocardial diastolic function and global longitudinal strain in patients with uncontrolled arterial hypertension
K. Vitlyanova, Naidenov St., N. Runev, E. Manov, R. Shabani, Y. Rangelov, K. Koshtikova, T. Donova
Internal Medicine
2013 Issue 12
Most read in this issue
- Contemporary view on liver impairment in heart failure
- Histiocytic sarcoma
- Serious risk related to oral use of sodium phosphate solution
- Inflammatory borrelia – associated dilated cardiomyopathy